Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.
about
Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cellsDevelopment, Maintenance, and Reversal of Multiple Drug Resistance: At the Crossroads of TFPI1, ABC Transporters, and HIF1In vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studiesGene therapy for brain tumors: basic developments and clinical implementationIn vivo models of primary brain tumors: pitfalls and perspectives.MR imaging features of high-grade gliomas in murine models: how they compare with human disease, reflect tumor biology, and play a role in preclinical trialsContemporary murine models in preclinical astrocytoma drug developmentInduction of selective blood-tumor barrier permeability and macromolecular transport by a biostable kinin B1 receptor agonist in a glioma rat modelFocused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study.Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasionExposure to N-ethyl-N-nitrosourea in adult mice alters structural and functional integrity of neurogenic sitesEarly gene expression analysis in 9L orthotopic tumor-bearing rats identifies immune modulation in molecular response to synchrotron microbeam radiation therapyRosmarinic Acid and Melissa officinalis Extracts Differently Affect Glioblastoma CellsMR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound.Controlled Drug Release and Chemotherapy Response in a Novel Acoustofluidic 3D Tumor Platform.Differential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas.Nitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines.Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model.Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma modelImaging the intratumoral-peritumoral extracellular pH gradient of gliomas.Preparation, biodistribution and neurotoxicity of liposomal cisplatin following convection enhanced delivery in normal and F98 glioma bearing rats.The integration of quantitative multi-modality imaging data into mathematical models of tumors.Immunocompetent murine models for the study of glioblastoma immunotherapyA genomics approach identifies selective effects of trans-resveratrol in cerebral cortex neuron and glia gene expression.Quantitative chemical exchange saturation transfer (CEST) MRI of glioma using Image Downsampling Expedited Adaptive Least-squares (IDEAL) fitting.Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumorsEffects of l-DOPA pre-loading on the uptake of boronophenylalanine using the F98 glioma and B16 melanoma models.Evaluation of unnatural cyclic amino acids as boron delivery agents for treatment of melanomas and gliomasBoron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax.Molecular targeting of glioblastoma: Drug discovery and therapiesIn vivo characterization of several rodent glioma models by 1H MRSConvection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors.Synthesis and evaluation of thymidine kinase 1-targeting carboranyl pyrimidine nucleoside analogs for boron neutron capture therapy of cancerEvaluation of TK1 targeting carboranyl thymidine analogs as potential delivery agents for neutron capture therapy of brain tumors.Cell death induced by ozone and various non-thermal plasmas: therapeutic perspectives and limitations.Fluoxetine modulates breast cancer metastasis to the brain in a murine modelResistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferon.Biometric evidence of diet-induced obesity in Lew/Crl rats.Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model.Seeing is believing: are cancer stem cells the Loch Ness monster of tumor biology?
P2860
Q24617423-05D27B7F-A556-4113-A71C-39036A23F299Q26778957-1DB2212C-BC9D-42E3-A15B-6BC0F0B122ECQ26820289-DC268BDA-DCBF-4DF2-B3BE-DF1E492EE04CQ26829086-AE30C3B2-B653-49AD-AEE9-A2A9FAE07FA6Q26862847-14660EEA-16C6-4F1F-B3D4-C7ACBFFEC078Q26863563-EF987D7C-191D-43E1-9E6D-BFBD4285B992Q27026937-983E265D-19FF-4627-9DA6-D6CB2AF19381Q27302402-69B7CFE9-7AF8-4127-99F5-2395D298CD06Q27334453-EC7972BA-32A7-4794-97EB-DCF616C527C5Q28263549-ED5723A7-B191-4648-B3C8-99FBBD2578F5Q28478704-29728E57-2C23-4D36-80AD-F881EAA1CB62Q28538112-4D23B02B-A01F-4CB9-98FE-2CE8882F90BDQ28829949-258042B9-5818-49A1-92CC-8C34FD322212Q30252977-009CC5D7-28FE-4C9A-94E3-5DABE7F6269DQ30357837-052E63D2-BA12-4225-B7E1-48834D901976Q30428613-97E9ABC9-2E09-43DF-AFA0-8FFE7B7EFA96Q30431810-8FB34111-158E-44AB-96CB-6BE3DF3F03C8Q30435074-4C929D29-B660-4842-9C28-C246475CE045Q30458838-E34CBDB4-CDDB-4092-A516-41DE4FEC21B7Q31036207-AC5F62D8-5431-4270-BC03-38D096559CBDQ31106992-BDCE4E7D-20F9-4B49-960A-F422255F739AQ33550040-2B9DFB73-0B64-414D-A1B5-1F68A5931D63Q33574853-E4945311-DBF9-440B-B584-B70770C24833Q33602768-43BD2767-95DF-441E-AF3D-82304E285668Q33669351-7137DF15-481A-4F5E-874E-611D485A8BD5Q33697847-4DD6DD39-F823-4D0C-85D6-384FEE159F0CQ33723694-8D270E7B-A40B-423B-BB49-0519BD1392A2Q33728100-A306297B-BCAA-46F5-829A-461AB74B25EDQ33759994-D7E0D777-1A1A-41CF-9A78-6651FD98E133Q33911283-DEDF1796-1908-4BF9-BA38-157AD7C5E510Q34033507-7D8A643C-4667-46AE-9A05-FE1E30DB161DQ34420122-C3EF9762-76B3-4A36-A1A9-F01D11A492FDQ34481269-60E190D5-C9F4-4AD9-9C51-3B52095B7E94Q34489859-10237495-C512-4DA0-83C1-0BB25BCB5EC3Q34545637-F6525BC8-AF92-45FE-B521-740E242334D2Q34565460-665E2935-3444-4B87-81CE-B62E0BCAD660Q34770256-3F150F9B-B501-4465-B4E4-6E14DE4038B4Q34819940-174E0FFE-C4BA-44EA-AACF-458F8FF065A4Q34977587-03D32699-0DC9-4524-B3AA-029C8F9168E3Q34978487-D28B0CD0-13D6-45EB-90FF-895BF89C62C0
P2860
Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rat brain tumor models in expe ...... BT4C, RT-2 and CNS-1 gliomas.
@en
Rat brain tumor models in expe ...... BT4C, RT-2 and CNS-1 gliomas.
@nl
type
label
Rat brain tumor models in expe ...... BT4C, RT-2 and CNS-1 gliomas.
@en
Rat brain tumor models in expe ...... BT4C, RT-2 and CNS-1 gliomas.
@nl
prefLabel
Rat brain tumor models in expe ...... BT4C, RT-2 and CNS-1 gliomas.
@en
Rat brain tumor models in expe ...... BT4C, RT-2 and CNS-1 gliomas.
@nl
P2860
P4510
P1476
Rat brain tumor models in expe ...... BT4C, RT-2 and CNS-1 gliomas.
@en
P2093
Balveen Kaur
Rolf F Barth
P2860
P2888
P304
P356
10.1007/S11060-009-9875-7
P577
2009-04-21T00:00:00Z